SERUM IgG – 4 at Test Zone Diagnostic Center

SERUM IgG – 4 at Test Zone Diagnostic Center

The SERUM IgG – 4 test is a highly specialized immunological assay designed to measure the concentration of Immunoglobulin G subclass 4 (IgG4) in a patient’s blood. Immunoglobulins, commonly known as antibodies, are glycoprotein molecules produced by plasma cells that play a critical role in the immune system by identifying and neutralizing foreign objects such as bacteria and viruses. Human IgG is divided into four distinct subclasses: IgG1, IgG2, IgG3, and IgG4. Among these, IgG4 is the least abundant, accounting for only 1% to 4% of total circulating IgG in healthy adults. Despite its low concentration, IgG4 has unique structural and functional properties, including the ability to undergo half-molecule exchange (Fab-arm exchange), which renders it functionally monovalent and largely anti-inflammatory under normal physiological conditions. However, when produced in excess, IgG4 is associated with a spectrum of fibroinflammatory disorders known collectively as IgG4-Related Disease (IgG4-RD).

At Test Zone Diagnostic Center, this test is performed using state-of-the-art automated immunoassay platforms, such as nephelometry or turbidimetry, ensuring the highest level of analytical sensitivity and clinical specificity. The clinical importance of measuring serum IgG4 levels lies in its utility as a primary diagnostic biomarker for IgG4-RD, a systemic condition characterized by tumor-like swelling of organs, a dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells, storiform fibrosis, and obliterative phlebitis. By providing precise quantification of this subclass, the SERUM IgG – 4 test at Test Zone Diagnostic Center assists clinicians in distinguishing this highly treatable, steroid-responsive condition from malignant tumors, primary autoimmune diseases, and chronic infectious processes, thereby preventing unnecessary surgical interventions and guiding targeted therapeutic strategies.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy of the SERUM IgG – 4 test results, patients are advised to adhere to the following preparation guidelines:

• No Strict Fasting Required: Fasting is generally not mandatory for this test. Patients can eat and drink normally unless instructed otherwise by their referring physician or if concurrent tests require fasting.
• Medication Disclosure: It is imperative to inform the healthcare provider of all current medications, particularly corticosteroids, immunosuppressive drugs, or monoclonal antibody therapies (such as rituximab), as these can significantly suppress immunoglobulin levels and potentially lead to false-negative results.
• Hydration: Adequate hydration is recommended prior to the procedure, as it facilitates easier venous access and a smoother blood collection process.
• Clinical Documentation: Patients should bring their referral slip, a summary of clinical symptoms, and any relevant previous laboratory or imaging reports to Test Zone Diagnostic Center to assist in comprehensive clinical correlation.

During the Procedure

The collection of the blood sample for the SERUM IgG – 4 test is a standard, minimally invasive outpatient procedure performed by highly trained phlebotomists at Test Zone Diagnostic Center:

• Patient Positioning: The patient is seated comfortably in a blood collection chair, and the arm is positioned to expose the antecubital fossa (the crease of the elbow).
• Site Selection and Sanitization: The phlebotomist identifies a suitable vein, typically the median cubital vein, and cleanses the overlying skin with an antiseptic swab (70% isopropyl alcohol) using a circular motion to prevent contamination.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube (typically a serum separator tube or red-top tube) is gently inserted into the vein. The patient may feel a brief, mild pinch.
• Sample Collection: The required volume of blood (usually 3 to 5 milliliters) is drawn into the tube. Once the collection is complete, the needle is carefully withdrawn, and immediate pressure is applied to the puncture site with a sterile gauze pad to promote hemostasis.
• Post-Procedure Care: A small adhesive bandage is applied to the site. The entire venipuncture process takes less than five minutes. The sample is then labeled with unique patient identifiers and sent to the laboratory for processing.

When is a SERUM IgG – 4 Performed?

Evaluation of Suspected Autoimmune Pancreatitis (AIP)

Autoimmune Pancreatitis (AIP) is a form of chronic pancreatitis that can clinically and radiographically mimic pancreatic ductal adenocarcinoma. Type 1 AIP is the pancreatic manifestation of IgG4-Related Disease. Physicians frequently request the SERUM IgG – 4 test when a patient presents with painless obstructive jaundice, a sausage-shaped pancreatic mass on imaging, or unexplained weight loss. Differentiating Type 1 AIP from pancreatic cancer is critical, as AIP responds remarkably well to corticosteroid therapy, sparing the patient from undergoing a highly invasive Whipple procedure (pancreaticoduodenectomy).

Investigation of Unexplained Salivary and Lacrimal Gland Swelling

Chronic, symmetrical, painless swelling of the lacrimal, submandibular, and parotid glands—historically referred to as Mikulicz’s disease—is a classic presentation of IgG4-RD. Clinicians order the SERUM IgG – 4 test to evaluate patients presenting with these symptoms to differentiate the condition from Sjögren’s syndrome, sarcoidosis, or salivary gland malignancies. Unlike Sjögren’s syndrome, patients with IgG4-related sialadenitis typically lack anti-SSA and anti-SSB antibodies but exhibit significantly elevated serum IgG4 levels, allowing for an accurate diagnostic pathway.

Assessment of Retroperitoneal Fibrosis

Retroperitoneal fibrosis (Ormond’s disease) is characterized by the development of abnormal fibrous tissue in the retroperitoneal space, which can encase and obstruct the ureters, abdominal aorta, and inferior vena cava. Patients often present with dull, poorly localized back or flank pain, lower extremity edema, or acute kidney injury. The SERUM IgG – 4 test is performed to determine if the retroperitoneal fibrosis is IgG4-related, which is essential because IgG4-related retroperitoneal fibrosis is highly responsive to medical immunosuppression, whereas non-IgG4-related cases may require extensive surgical ureterolysis.

Diagnosis of IgG4-Related Systemic Disease (IgG4-RD)

Because IgG4-RD is a multi-organ systemic disease, it can manifest in virtually any organ system, including the lungs (interstitial pneumonitis), kidneys (tubulointerstitial nephritis), thyroid (Riedel’s thyroiditis), and aorta (periaortitis). A physician will order a SERUM IgG – 4 test when a patient exhibits multi-organ involvement, unexplained lymphadenopathy, or pseudotumors in multiple anatomical sites. Identifying elevated IgG4 levels in the serum provides strong biochemical evidence supporting a systemic IgG4-RD diagnosis, which is then confirmed via histopathological examination.

Monitoring Therapeutic Response to Corticosteroids

Once a diagnosis of IgG4-RD is established and treatment with systemic corticosteroids or steroid-sparing agents (such as rituximab) is initiated, serial measurements of SERUM IgG – 4 are performed. Monitoring these levels over time helps clinicians assess the efficacy of the treatment, confirm biochemical remission, and detect early disease relapses. A rising trend in serum IgG4 levels during or after treatment taper often precedes clinical symptom recurrence, allowing for proactive therapeutic adjustments.

What Does a SERUM IgG – 4 Detect?

The SERUM IgG – 4 test is instrumental in detecting, evaluating, and monitoring several clinical conditions and physiological states. It assists in identifying:

• Elevated levels diagnostic of IgG4-Related Disease (IgG4-RD).
• Type 1 Autoimmune Pancreatitis (AIP).
• IgG4-related Sclerosing Cholangitis (IgG4-SC), which mimics primary sclerosing cholangitis or cholangiocarcinoma.
• Mikulicz’s disease (symmetrical swelling of lacrimal and salivary glands).
• Küttner’s tumor (chronic sclerosing sialadenitis affecting the submandibular glands).
• IgG4-related retroperitoneal fibrosis (Ormond’s disease).
• IgG4-related tubulointerstitial nephritis (kidney involvement leading to renal insufficiency).
• IgG4-related ophthalmic disease, including orbital pseudotumor and dacryoadenitis.
• Riedel’s thyroiditis (a rare, fibrotic thyroid condition).
• IgG4-related lung disease, presenting as pulmonary nodules or interstitial lung disease.
• IgG4-related lymphadenopathy (unexplained lymph node enlargement).
• IgG4-related aortitis and periaortitis (inflammation of the aorta).
• IgG4-related pachymeningitis (inflammation of the dura mater).
• IgG4-related prostatitis and prostatic enlargement.
• IgG4-related skin lesions, including erythematous plaques, papules, or nodules.
• Distinction between IgG4-related systemic disease and mimicking malignancies.
• Distinction between IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.
• Efficacy of corticosteroid therapy (indicated by declining IgG4 levels).
• Early signs of disease relapse or flare-ups (indicated by rising IgG4 levels).
• Mild, non-specific elevations associated with atopic diseases, such as asthma or atopic dermatitis.
• Elevations secondary to certain chronic parasitic infections.
• Elevations associated with pemphigus vulgaris and other autoimmune bullous dermatoses.
• Normal IgG4 levels, which can help rule out active IgG4-RD (though normal levels do not entirely exclude the diagnosis in some biopsy-proven cases).
• Hypogammaglobulinemia or selective IgG subclass deficiencies (when levels are abnormally low).

Turnaround Time and Report Access at Test Zone Diagnostic Center

At Test Zone Diagnostic Center, we understand that timely and accurate results are crucial for effective clinical decision-making. The SERUM IgG – 4 test is a specialized immunological analysis that requires meticulous laboratory processing. Utilizing advanced automated nephelometric and turbidimetric platforms, our highly qualified laboratory scientists process samples with strict adherence to international quality standards. The typical turnaround time for the SERUM IgG – 4 report is 24 to 48 hours from the time of sample collection.

Once the analysis is complete, the report undergoes a rigorous multi-level review by our consultant pathologists to ensure absolute accuracy. Patients and referring physicians are notified immediately via SMS when the report is ready. Reports can be accessed and downloaded online through the secure patient portal on the official Test Zone Diagnostic Center website. Physical copies of the reports are also available for collection at our main diagnostic facility or can be delivered via our dedicated home delivery services, ensuring maximum convenience for our patients.

SERUM IgG – 4 Findings Overview

The following table provides an overview of potential findings from a SERUM IgG – 4 test, their clinical interpretations, and associated parameters:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Serum IgG4 Concentration	Within reference range (typically 8 to 140 mg/dL or 0.08 to 1.40 g/L)	Significantly elevated (>135–140 mg/dL, often exceeding 2 to 3 times the upper limit of normal)
Ratio of IgG4 to Total IgG	Less than 5% to 8% of total IgG	Elevated ratio (frequently >10%, and up to 40% in active IgG4-RD)
Pancreatic Enzymes (Amylase/Lipase)	Within normal physiological limits	Elevated or depressed depending on the degree of pancreatic parenchymal damage
Biliary Markers (Bilirubin, ALP, GGT)	Normal levels, indicating unobstructed bile flow	Elevated alkaline phosphatase (ALP) and bilirubin, suggesting biliary strictures
Renal Markers (Creatinine, BUN)	Normal renal function parameters	Elevated Creatinine and BUN, indicating tubulointerstitial nephritis
Inflammatory Markers (CRP, ESR)	Normal or mildly elevated	Moderately to highly elevated CRP and ESR, reflecting systemic inflammation
Thyroid Hormones (TSH, Free T4)	Euthyroid state (normal TSH and thyroid hormone levels)	Elevated TSH and low Free T4, indicating hypothyroidism secondary to Riedel’s thyroiditis

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Test Zone Diagnostic Center for SERUM IgG – 4?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified consultant pathologists and technologists specializing in clinical immunology.
• Patient-Focused Care: We prioritize patient comfort and safety, providing a seamless and stress-free experience from registration to sample collection.
• Quality Diagnostic Services: Test Zone Diagnostic Center is committed to maintaining the highest standards of analytical precision and clinical accuracy.
• Professional Reporting: Our reports are comprehensive, easy to read, and include clear reference ranges to assist clinicians in precise diagnosis.
• Modern Diagnostic Approach: We utilize state-of-the-art automated analyzers and evidence-based laboratory protocols for all immunological assays.
• Comfortable Environment: Our modern, hygienic, and well-designed collection centers ensure a pleasant environment for all patients.
• Convenient Location: Strategically located to serve patients efficiently, offering easy access to advanced diagnostic testing.
• Commitment to Accurate Diagnosis: We employ stringent internal and external quality control measures to ensure that every test result is highly reliable.